Detalhe da pesquisa
1.
Is qualitative social research in global health fulfilling its potential?: a systematic evidence mapping of research on point-of-care testing in low- and middle-income contexts.
BMC Health Serv Res
; 24(1): 172, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326871
2.
Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.
Cell Mol Life Sci
; 69(3): 389-404, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22015612
3.
Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.
Bioorg Med Chem
; 20(5): 1779-93, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22304848
4.
Discovery and validation of SIRT2 inhibitors based on tenovin-6: use of a ¹H-NMR method to assess deacetylase activity.
Molecules
; 17(10): 12206-24, 2012 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23079492
5.
The discovery of nongenotoxic activators of p53: building on a cell-based high-throughput screen.
Semin Cancer Biol
; 20(1): 40-5, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20206696
6.
Draft Genome Sequences of 10 Bacteria from the Marine Pseudoalteromonas Group.
Microbiol Resour Announc
; 10(32): e0040421, 2021 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382833
7.
Correction: Modulation of p53 C-Terminal Acetylation by Mdm2, p14ARF, and Cytoplasmic SirT2.
Mol Cancer Ther
; 22(12): 1503, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037420
8.
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib.
PLoS One
; 13(4): e0195956, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684045
9.
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Nat Commun
; 14(1): 5019, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596290
10.
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Nat Commun
; 9(1): 1107, 2018 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29549331
11.
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Nat Commun
; 9(1): 2071, 2018 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29789663
12.
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.
Oncotarget
; 6(18): 16488-506, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26029997
13.
Acetylation site specificities of lysine deacetylase inhibitors in human cells.
Nat Biotechnol
; 33(4): 415-23, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25751058
14.
Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2.
Mol Cancer Ther
; 12(4): 471-80, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23416275
15.
Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner.
Mol Cancer Ther
; 12(4): 352-60, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23322738
16.
Mechanism-specific signatures for small-molecule p53 activators.
Cell Cycle
; 10(10): 1590-8, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21490429
17.
Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.
J Med Chem
; 52(9): 2673-82, 2009 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19419202
18.
Characterization, chemical optimization and anti-tumour activity of a tubulin poison identified by a p53-based phenotypic screen.
Cell Cycle
; 7(21): 3417-27, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18971638
19.
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.
Cancer Cell
; 13(5): 454-63, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18455128
20.
Evaluation of 4'-substituted bicyclic pyridones as non-steroidal inhibitors of steroid 5alpha-reductase.
Bioorg Med Chem Lett
; 17(13): 3603-7, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17490876